The hims stock rose 8% this week, according to Quiver Quantitative's price data sourced from Polygon, and the ticker ranked as the 34th most-searched on Quiver's platform over the past week out of fifty tracked tickers.
Quiver's records show insider trading activity has been concentrated on the sell side, with forty open market insider trades reported in the past six months and no insider purchases recorded.
Senior executives accounted for the largest insider sales, as reported by Quiver Quantitative: Oluyemi Okupe, the chief financial officer, sold 346,447 shares for an estimated twenty million two hundred thirty-five thousand dollars; Andrew Dudum, the chief executive officer, sold 240,771 shares for an estimated twelve million six hundred seventy-seven thousand dollars.
Other named officers who sold shares include Michael Chi, chief operating officer, who sold 34,899 shares for about one million six hundred sixteen thousand dollars, and Patrick Harrison Carroll, chief medical officer, who sold 20,042 shares for about eight hundred seventy-three thousand dollars.
Additional insider sales reported by Quiver include Soleil Boughton, chief legal officer, who sold 20,467 shares for about eight hundred thirty-nine thousand dollars, Irene Becklund, PAO, who sold 16,821 shares for about seven hundred thirty-three thousand dollars, and Deborah M. Autor, chief policy officer, who sold 7,054 shares for about two hundred fifty-eight thousand dollars.
Quiver also reports that institutional activity has been mixed recently, with two hundred thirty-nine institutional investors adding shares and three hundred sixty-six decreasing positions in their most recent quarter, and several large portfolio reductions by named funds.
Analyst Coverage Price Targets And Data Tools
Wall Street coverage tracked by Quiver shows both buy and sell viewpoints, with one firm issuing a buy rating and one firm issuing a sell rating on the stock, as reported by Quiver Quantitative.
Canaccord Genuity is listed with a buy rating, while B of A Securities is listed with an underperform rating, according to Quiver's aggregation of analyst reports.
Quiver also reports multiple analyst price targets, stating that ten analysts have issued targets with a median target of twenty-one dollars, and it lists individual targets from named analysts and firms.
Named target examples in Quiver's data include a twenty-five dollar target from a Barclays analyst, a twenty-one dollar target from a Morgan Stanley analyst, and a range of lower targets including thirteen point two five dollars from a Citigroup analyst and seventeen dollars from a TD Cowen analyst.
The Quiver article notes large institutional reductions by several named managers and highlights the platform's dashboards for tracking insider transactions, institutional holdings, analyst forecasts, and price targets, and it reminds readers that the information is not financial advice and may contain mapping anomalies.
